296 related articles for article (PubMed ID: 19218271)
1. Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.
Spriet I; Annaert P; Meersseman P; Hermans G; Meersseman W; Verbesselt R; Willems L
J Antimicrob Chemother; 2009 Apr; 63(4):767-70. PubMed ID: 19218271
[TBL] [Abstract][Full Text] [Related]
2. Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation.
Ruiz S; Papy E; Da Silva D; Nataf P; Massias L; Wolff M; Bouadma L
Intensive Care Med; 2009 Jan; 35(1):183-4. PubMed ID: 18795256
[No Abstract] [Full Text] [Related]
3. Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation.
Lin XB; Hu XG; Xia YZ; Liu XM; Liang T; Chen X; Cai CJ
J Chemother; 2022 Jul; 34(4):272-276. PubMed ID: 34904531
[TBL] [Abstract][Full Text] [Related]
4. The impact of extracorporeal membrane oxygenation on antifungal pharmacokinetics: A systematic review.
Jendoubi A; Pressiat C; De Roux Q; Hulin A; Ghaleh B; Tissier R; Kohlhauer M; Mongardon N
Int J Antimicrob Agents; 2024 Feb; 63(2):107078. PubMed ID: 38161046
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
Hahn J; Choi JH; Chang MJ
J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
[TBL] [Abstract][Full Text] [Related]
6. Variable Sequestration of Antifungals in an Extracorporeal Membrane Oxygenation Circuit.
Lyster H; Pitt T; Maunz O; Diamond S; Roberts JA; Brown D; Mills J; Armstrong-James D; Gerovasili V; Carby M; Dunning J; Simon A; Reed A
ASAIO J; 2023 Mar; 69(3):309-314. PubMed ID: 36731055
[TBL] [Abstract][Full Text] [Related]
7. Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study.
Shekar K; Roberts JA; Mcdonald CI; Ghassabian S; Anstey C; Wallis SC; Mullany DV; Fung YL; Fraser JF
Crit Care; 2015 Apr; 19(1):164. PubMed ID: 25888449
[TBL] [Abstract][Full Text] [Related]
8. Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis.
Spriet I; Delaere L; Lagrou K; Peetermans WE; Maertens J; Willems L
J Antimicrob Chemother; 2009 Oct; 64(4):877-8. PubMed ID: 19684077
[No Abstract] [Full Text] [Related]
9. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG
Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
11. Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.
Shekar K; Roberts JA; Barnett AG; Diab S; Wallis SC; Fung YL; Fraser JF
Crit Care; 2015 Dec; 19():437. PubMed ID: 26667471
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
MacCallum DM; Whyte JA; Odds FC
Antimicrob Agents Chemother; 2005 Sep; 49(9):3697-701. PubMed ID: 16127042
[TBL] [Abstract][Full Text] [Related]
13. Decreasing voriconazole requirement in a patient after extracorporeal membrane oxygenation discontinuation: A case report.
Peterson EL; Chittick PJ; Richardson CL
Transpl Infect Dis; 2021 Jun; 23(3):e13545. PubMed ID: 33316840
[TBL] [Abstract][Full Text] [Related]
14. Fluctuating Voriconazole Concentrations during Extracorporeal Membrane Oxygenation.
Vu T; Feih J; Juul J
J Pharm Pract; 2023 Aug; 36(4):998-1001. PubMed ID: 35612553
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange.
Spriet I; Brüggemann RJ; Annaert P; Meersseman P; Van Wijngaerden E; Lagrou K; Willems L
Ther Drug Monit; 2013 Feb; 35(1):141-3. PubMed ID: 23296095
[TBL] [Abstract][Full Text] [Related]
16. Voriconazole Sequestration During Extracorporeal Membrane Oxygenation for Invasive Lung Aspergillosis: A Case Report.
Mathieu A; Thiboutot Z; Ferreira V; Benoit P; Grandjean Lapierre S; HÉtu PO; Halwagi A
ASAIO J; 2022 Mar; 68(3):e56-e58. PubMed ID: 33788798
[TBL] [Abstract][Full Text] [Related]
17. Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration.
Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Brüggemann RJ; Lefrant JY; Roberts JA
Clin Pharmacokinet; 2017 Sep; 56(9):1057-1068. PubMed ID: 28035589
[TBL] [Abstract][Full Text] [Related]
18. [Effect of extracorporeal membrane oxygenation on pharmacokinetics of antimicrobial drugs: recent progress and recommendations].
Zhang Y; Zeng Z; Zhang Q; Ou Q; Chen Z
Nan Fang Yi Ke Da Xue Xue Bao; 2021 May; 41(5):793-800. PubMed ID: 34134970
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.
Sherwin J; Heath T; Watt K
Clin Ther; 2016 Sep; 38(9):1976-94. PubMed ID: 27553752
[TBL] [Abstract][Full Text] [Related]
20. The impact of a transjugular intrahepatic portosystemic shunt on the pharmacokinetics of caspofungin in a critically ill patient.
Spriet I; Meyfroidt G; Maleux G; Verslype C; Willems L
Pharmacology; 2012; 90(5-6):247-50. PubMed ID: 23007631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
